Avastin: Just Tip Of Cancer Immunotherapy's Iceberg?
NEW YORK - The curiosity of new investors and an apparent financial upswing (heralded partly by the opening squeak of an initial public offerings window) gained credit for drawing a record number of registrants to the Biotechnology Industry Organization's CEO & Investor Conference last week.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter